Sinus Infection Guide

What is a sinus infection?

Sinusitis, more precisely called rhinosinusitis, is inflammation of the lining of the nose and of the air-filled spaces that surround it. The preferred term matters because nasal and sinus lining usually become inflamed together, not as separate problems. Congestion, thick drainage, facial pressure, reduced smell, cough, fatigue, and ear pressure can all occur. Acute symptoms often follow a viral upper respiratory infection. About 28.9 million U.S. adults, or 11.6%, reported being diagnosed with sinusitis in the 2018 National Health Interview Survey.^[5][12]

There are four paired sinus groups: maxillary sinuses in the cheeks, ethmoid sinuses between the eyes, frontal sinuses above the eyes, and sphenoid sinuses deeper behind the nose. Much of the normal mucus drainage from the frontal, maxillary, and anterior ethmoid sinuses passes through a narrow shared region called the middle meatus or osteomeatal complex. Swelling at this bottleneck can impair ventilation and drainage, which helps explain why a routine cold can produce sinus pressure.^[22][29]

The maxillary sinuses are commonly involved. Their opening is positioned relatively high on the inner sinus wall, so drainage depends on ciliary movement and airflow rather than simply flowing downhill. A cold, allergies, or an anatomic narrowing can therefore create symptoms even when there is no bacterial infection. The everyday label “sinus infection” can be misleading because the inflammation may be viral, allergic, bacterial, dental in origin, or part of chronic disease.^[12][22][29]

For most people, the useful question is not whether mucus is present but how the illness behaves over time. Improvement after a few days favors a self-limited viral illness. Symptoms that persist without improvement, become severe, or improve and then clearly worsen deserve a different assessment.^[1][21][22]

What causes sinus infections?

Viruses cause most acute cases. CDC and IDSA materials estimate that 90% to 98% of acute sinus infections are viral, and only about 0.5% to 2.0% of common colds progress to acute bacterial rhinosinusitis, often shortened to ABRS. A viral upper respiratory infection is therefore the usual upstream trigger, not a failure to treat a cold early enough.^[3][4][9]

A cold causes swelling of the nasal and sinus lining. That swelling can narrow the osteomeatal drainage pathways, reduce mucus clearance, and create a temporary environment in which bacteria may multiply. In ABRS, the organisms most often recovered are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Staphylococcus aureus and other streptococci account for a minority of cases.^[29][30]

The microbiology is different when disease is chronic or arises from a tooth. Anaerobes are prominent in chronic sinus infection and may make up roughly 70% of organisms in odontogenic sinusitis series. A dental abscess, apical periodontitis, implant complication, or communication with the maxillary sinus after extraction can seed the nearby maxillary sinus. Unilateral maxillary pressure, foul drainage, or a dental history should prompt consideration of this cause rather than repeated empiric treatment for a routine cold.^[30][31]

Predisposing factors include allergic rhinitis, nasal polyps, smoke exposure, and structural narrowing such as a deviated septum or concha bullosa. Less common contributors include impaired ciliary clearance in primary ciliary dyskinesia or cystic fibrosis, immune deficiency, and conditions associated with upper-airway irritation. These factors do not prove that an episode is bacterial, but they can explain recurrent, prolonged, or difficult-to-clear symptoms.^[12][13][14]

A clinician may look for a non-sinus cause when symptoms are persistent, strongly one-sided, or unusual. Migraine, dental pain, allergic rhinitis, and chronic nasal inflammation can all feel like “sinus trouble,” while a true bacterial episode is still diagnosed mainly from the clinical pattern rather than from mucus color alone.^[12][21]

Because these pathways are shared, a person can have striking pressure without a true infection. Bacterial infection is a possible downstream event after obstruction, not the inevitable explanation for every episode. That distinction is why recurrent symptoms merit a search for allergic, dental, structural, or chronic inflammatory contributors instead of repeated treatment based on a single symptom.^[12][14][29]

Viral vs bacterial: how to tell them apart

Clinicians diagnose uncomplicated ABRS from the symptom pattern rather than a routine scan or culture. The 2025 AAO-HNS guideline uses purulent nasal drainage plus nasal obstruction or facial pain, pressure, or fullness, together with either persistence for 10 days without improvement or double worsening within 10 days after initial improvement.^[1][10]

EPOS 2020 describes rhinosinusitis as at least two symptoms, with one being nasal blockage or nasal discharge. Facial pain or pressure and reduced or lost smell can be the additional symptoms. This definition helps identify rhinosinusitis, but the course of illness helps separate a likely viral episode from a possible bacterial one.^[14]

A practical distinction is that a viral cold should trend toward improvement, even if congestion and colored mucus are unpleasant. Bacterial disease becomes more plausible when there is no improvement by day 10, when there is a new worse phase after initial recovery, or when severe fever and purulent drainage occur early. The BMJ review notes that three or more findings, including unilateral discolored discharge, severe unilateral local pain, fever above 38°C, elevated CRP or ESR, and double sickening, support a bacterial assessment when testing is clinically appropriate.^[1][3][22]

Yellow or green mucus does not by itself distinguish bacterial from viral illness. Color reflects inflammatory cells and concentration of secretions, so it needs to be interpreted with duration, trajectory, fever, and severity. Routine imaging is not useful for a straightforward episode because mucosal swelling can be seen with viral illness as well.^[1][21]

Even when ABRS is clinically likely, many uncomplicated cases resolve without an antibiotic. The Cochrane review found the average benefit of antibiotics modest, which is why a follow-up plan and symptom care can be safer than treating every persistent cold as a bacterial infection.^[8]

A careful history is usually more informative than a rapid request for imaging. The clinician may ask exactly when the first symptoms began, whether there was a genuine recovery period before a second decline, whether pain is strongly one-sided, and whether fever has been persistent. This is also why a person should avoid labeling a day-three cold as “bacterial” solely because discharge has changed color.^[1][14][21]

Symptoms can overlap, so no individual feature has perfect accuracy. The value of the criteria is that they avoid a reflex prescription at the start of a typical cold while identifying the trajectories that deserve a more focused clinical discussion.^[1][3][14]

What changed in the 2025 AAO-HNS guideline update?

The 2025 AAO-HNS Adult Sinusitis Update replaced the 2015 guideline and organizes care into 14 Key Action Statements. Its most visible practical change is that clinicians should offer watchful waiting as the initial management choice for uncomplicated ABRS when follow-up is available. The 2015 guideline presented watchful waiting or antibiotics as options, while the update more clearly centers a stewardship-first discussion.^{[1][2][10][25]}

The update also tightened the timing of management. For adults who start antibiotics, the recommended duration is now 5 to 7 days rather than the prior 5 to 10 day range. For a person who is not improving or is worsening, reassessment moves from 7 days to 3 to 5 days. These changes encourage an earlier check that the diagnosis and plan still fit the clinical course rather than simply extending therapy.^[1][10][25]

Three chronic-rhinosinusitis recommendations are new or newly explicit. The guideline advises against routine antimicrobials for chronic rhinosinusitis without an acute exacerbation. It advises against routine biologics for CRS without nasal polyps, called CRSsNP. For CRS with nasal polyps, called CRSwNP, it recommends patient education about the potential role of biologic medicines rather than an automatic prescription.^[1][10][25]

The direction of travel reflects both antibiotic stewardship and the limits of average benefit in uncomplicated illness. CDC identifies sinusitis as a common setting for antibiotic prescribing, while the Cochrane evidence finds only marginal average benefit from antibiotics for uncomplicated acute rhinosinusitis. A guideline recommendation for watchful waiting is therefore an active clinical plan, not a dismissal of symptoms.^[6][8][10]

The update does not say that every person should wait. Severe onset, important comorbidity, inability to arrange follow-up, medication risks, and red flags all change the decision. The comparison chart and table below summarize the policy shift, but an individual assessment still depends on symptom pattern and safety.^[1][10]

The guideline also continues to emphasize separating acute uncomplicated disease from chronic rhinosinusitis and from recurrent acute episodes. That distinction reduces the risk that a long-standing inflammatory problem is managed with the same short-course approach used for a new acute bacterial pattern.^[1][10]

For patients, the practical message is to expect a conversation about options, not a one-size-fits-all antibiotic. The update asks clinicians to pair observation with access to reassessment, clear return precautions, and symptom support.^[1][10][25]

The decision framework: watch, treat, or go to the ER

For a mild illness that is improving, home symptom care is generally appropriate. For symptoms that meet an ABRS pattern without danger signs, watchful waiting with a reliable plan for follow-up is the current first choice. A licensed clinician, whether through telehealth or in-person care, can review the timeline, allergies, medicines, and whether an examination is needed.^[1][10][11]

Watchful waiting is not the right pathway for severe onset. Fever of at least 39°C (102°F) with purulent nasal drainage or facial pain for 3 to 4 consecutive days at the start of illness is an exception that warrants prompt clinical assessment and can support antibiotic treatment. Persistent symptoms at least 10 days without improvement and double worsening also warrant a clinician-guided decision.^[1][3][10]

The “go to the ER” branch is about possible spread beyond the sinuses, not ordinary pressure or colored mucus. Proptosis, vision change, pain or inability to move an eye normally, a focal neurologic deficit, altered mental status, meningismus, or rapid worsening in an immunocompromised person needs urgent in-person evaluation. These signs can indicate orbital, cavernous sinus, or intracranial complications.^[18][19][32]

A practical decision plan has three parts: identify the symptom pattern, provide comfort measures while observing, and name the exact point for reassessment. People who are unable to hydrate, have uncontrolled pain, are clinically fragile, or cannot obtain follow-up should not be managed as though every episode were routine.^[1][10]

CDC reports that about 75% of sinusitis visits result in an antibiotic prescription. Thoughtful prescribing avoids rash, diarrhea, interactions, and resistance when the expected benefit is small, while preserving rapid treatment for people whose presentation is genuinely severe or complicated.^[6][8][9]

For a person monitoring at home, it helps to write down the first day of illness and whether each day is better, unchanged, or worse. This simple record makes persistence and double worsening easier to recognize during a telehealth visit or follow-up call.^[1][10]

When the diagnosis is uncertain, the safest next step is often reassessment rather than escalation based on anxiety alone. An exam can check the eyes, teeth, lungs, vital signs, and nasal findings that cannot be fully characterized through symptoms alone.^[1][11][18]

Watchful waiting: the new first move for most bacterial cases

Watchful waiting does not mean ignoring symptoms. It means using symptom relief and a specific follow-up plan instead of starting an antibiotic immediately when a person has uncomplicated ABRS and can be reassessed if they do not improve. The 2025 guideline specifically recommends offering this option, with shared decision-making about the expected course and warning signs.^[1][10]

“Assurance of follow-up” should be concrete. It can mean a scheduled telehealth or in-person check-in at 3 to 5 days, instructions to contact the clinician sooner for severe worsening, and a clear pathway to an in-person examination if eye, neurologic, or dehydration concerns arise. Some plans include a contingency prescription only after the clinician and patient agree on the symptom change that would trigger its use.^[1][10]

The 2018 Cochrane review found that uncomplicated acute rhinosinusitis often improves without antibiotics and that the average benefit from antibiotics is marginal. That tradeoff matters because antibiotics can cause rash, diarrhea, yeast symptoms, drug interactions, and, less commonly, serious antibiotic-associated diarrhea. Watchful waiting is intended to avoid these predictable harms when the chance of a meaningful benefit is low.^[8]

If a person becomes worse, fails to improve in the agreed interval, or develops a more concerning pattern, reassessment is the key next step. The clinician can revisit the diagnosis, check for an alternative source such as dental disease, and decide whether an antibiotic or examination is now appropriate.^[1][10][31]

When antibiotics are used for uncomplicated disease, narrower first-line choices remain important. In a large retrospective cohort, first-line antibiotics were not inferior to second-line drugs for acute uncomplicated sinusitis. That older study does not replace current guidelines, but it supports the stewardship principle of avoiding unnecessarily broad therapy.^[34]

A successful observation period also gives patients a chance to use irrigation, nasal steroid treatment when appropriate, and pain relief consistently. Improvement during that interval is useful clinical information and can avoid a prescription that will not change the natural course of the illness.^[1][7][8]

Observation is also compatible with seeking care sooner. A patient does not need to wait for a scheduled check-in if fever becomes severe, pain is escalating, new eye symptoms develop, or the ability to drink and take medicines is impaired.^[1][10][18]

When antibiotics are actually needed

Antibiotics may be reasonable when symptoms persist at least 10 days without improvement, double worsen, or have severe onset. The 2025 AAO-HNS first-line choice for adults is amoxicillin with or without clavulanate for five to seven days. A person who fails to improve or worsens should be reassessed within three to five days, rather than simply continuing the same plan without review.^[1][10][23]

IDSA recommends high-dose amoxicillin-clavulanate for adults with factors that raise concern for resistant organisms or a more serious course, including recent antibiotic exposure in the prior 4 to 6 weeks, severe infection, immunocompromise, and relevant exposure risks such as daycare contact. The final choice should account for local resistance patterns, allergy history, kidney function, pregnancy, and medicines that may interact.^[3][23]

Clavulanate adds activity against beta-lactamase-producing organisms. This matters because H. influenzae and M. catarrhalis are among common ABRS isolates, alongside S. pneumoniae. It does not mean every patient needs broader therapy, but it explains why amoxicillin-clavulanate is often selected when resistance risk or clinical severity is higher.^[3][30]

For adults with a genuine penicillin allergy, doxycycline or a respiratory fluoroquinolone can be alternatives under IDSA guidance. Local practice varies. Stanford’s stewardship guidance, for example, advises against routine doxycycline in its setting because pneumococcal resistance can be substantial. A clinician should distinguish an intolerance from an immediate allergy because that distinction can broaden or narrow safe options.^[3][20][26]

Fluoroquinolones are generally reserved for situations in which safer first-line options are unsuitable. Their safety concerns include tendon injury, dysglycemia, mental-health effects, and vascular warnings, so they are not casual substitutes for a short uncomplicated illness. The antibiotic decision should be individualized rather than based only on the intensity of pressure or mucus color.^[3][20]

Antibiotics do not treat viral rhinosinusitis, allergic inflammation, migraine, or most chronic symptoms. If an episode is repeatedly one-sided, follows dental pain, or fails reasonable first-line management, reassessment for an odontogenic source, chronic disease, or a non-sinus cause is more useful than repeated empiric courses.^[1][13][31]

A new antibiotic is not automatically the answer when a first course fails. The guideline approach is to reassess whether the symptoms were bacterial, whether the person has a complication or an alternative diagnosis, and whether factors such as resistant organisms or dental infection change the plan.^[1][3][31]

Completing the prescribed course as directed is important when an antibiotic has been started. However, a new rash, severe diarrhea, breathing symptoms, or other possible medication reaction should prompt timely medical advice rather than taking another dose without guidance.^[3][23]

Comparison table: amoxicillin, amox-clavulanate, and alternatives

These are reference doses from guideline sources, not a personal prescription. High-dose amoxicillin-clavulanate, often 2 g/125 mg twice daily in an extended-release regimen when appropriate, is reserved for resistant-pneumococcus contexts and other higher-risk situations rather than used automatically. The exact formulation and dose must be selected by a clinician.^[3][23][26]

Kidney function can change both dose and interval, especially for older adults and people with chronic kidney disease. Pregnancy also changes the risk-benefit discussion. Amoxicillin, amoxicillin-clavulanate, and some cephalosporins are commonly considered when an antibiotic is needed in pregnancy, whereas doxycycline and fluoroquinolones are not usual first-line choices. Individual allergy history and obstetric guidance remain important.^[3][23]

The table should not be used to self-start leftovers or to substitute one antibiotic for another. Local resistance, prior antibiotic use, drug interactions, and the possibility that the problem is viral or dental all influence whether any antibiotic is appropriate.^{[1][3][16][26]}

Symptom relief that works: what the evidence supports

Symptom relief is worthwhile whether the illness is viral, bacterial, or being observed before an antibiotic decision. Saline irrigation and intranasal corticosteroids, often called INCS, are reasonable options. In the Cochrane review of acute sinusitis, 73% of people using an intranasal steroid had resolution or improvement compared with 66.4% using placebo, a relative risk of 1.11 (95% CI 1.04 to 1.18). That is a modest average benefit, not an instant cure.^[7]

The effect of an intranasal steroid usually builds over days to weeks because it reduces local inflammation rather than immediately opening the nose. In one included trial, mometasone furoate 400 micrograms per day was more effective than 200 micrograms per day for symptom improvement, with a relative risk of 1.10 (95% CI 1.02 to 1.18). Dose and product choice should follow the labeled directions or a clinician’s recommendation.^[7][24]

A head-to-head randomized trial also found mometasone furoate nasal spray more effective for acute rhinosinusitis symptom relief than both amoxicillin and placebo. This supports using nasal anti-inflammatory treatment as part of symptom care, while recognizing that a person with severe disease or a clear bacterial pattern may need a different plan.^[33]

Acetaminophen or an NSAID can help pain, pressure, fever, and headache when they are safe for the individual. Oral pseudoephedrine and a topical spray such as oxymetazoline may give short-term congestion relief, but topical decongestant use beyond three days can cause rebound congestion, called rhinitis medicamentosa. People with hypertension, heart disease, glaucoma, prostate symptoms, or medication interactions should ask a clinician or pharmacist before using decongestants.^[12][21][24]

Antihistamines are useful when allergic rhinitis is also present, but they are not routinely needed for uncomplicated infectious rhinosinusitis and can dry secretions. Rest, fluids as tolerated, and avoiding smoke help comfort, although none replaces reassessment when symptoms worsen or danger signs appear.^[12][14][21]

Evidence supports observation and symptom care for uncomplicated cases because antibiotics provide only marginal average benefit. Relief measures make a watchful-waiting plan more tolerable while the clinical trajectory becomes clear.^[1][7][8]

Products with multiple cold medicines can accidentally duplicate acetaminophen or a decongestant. Checking the active ingredients is particularly important for people who use combination products or take medicines for blood pressure, sleep, mood, or attention.^[12][24]

How to use nasal irrigation and intranasal steroids correctly

For nasal irrigation, use a clean device and water that is distilled, sterile, or previously boiled and cooled. Tap water is safe to drink in many settings but is not reliably safe for rinsing the nasal passages. Rare, fatal amoebic meningoencephalitis from Naegleria fowleri has been linked to unsafe nasal water exposure, which is why water preparation is a non-negotiable part of the technique.^[17][24]

A premixed packet is the simplest way to make an isotonic saline solution, about 0.9% salt. Some people prefer hypertonic solutions, about 2% to 3%, but they can sting. For chronic rhinosinusitis, high-volume irrigation, generally more than 200 mL per side, has better evidence than a light mist because it can reach more of the nasal cavity. Stop if it causes marked pain, bleeding, or ear pressure and ask a clinician for advice.^[17]

For an intranasal steroid spray, gently clear the nose first, keep the head upright, and aim the nozzle slightly outward toward the ear, away from the middle septum. This lateral angle reduces septal irritation and nosebleeds. Do not sniff hard after spraying, because the medicine may run into the throat instead of remaining on the nasal lining where it is intended to work.^[24]

Use the spray daily and consistently, not only on the worst day, unless a clinician has given a different plan. Product labels provide age limits, dosing, and situations in which a clinician should be consulted. Significant recurrent bleeding, new facial swelling, visual symptoms, or severe pain is not a technique problem and needs assessment.^[17][24]

Clean the irrigation device after each use and allow it to dry completely between rinses. Mixing a fresh solution and following the device instructions makes contamination and irritation less likely. If a person cannot comfortably perform high-volume rinses, a clinician can help identify a lower-volume option that still fits the treatment plan.^[17][24]

Chronic and recurrent sinusitis: a different problem

Chronic rhinosinusitis, or CRS, is not simply a cold that lasts too long. EPOS and U.S. guidance define it by symptoms lasting at least 12 weeks plus objective evidence of inflammation. Objective evidence can be edema, polyps, or purulence seen on nasal endoscopy, or mucosal thickening on a CT scan when imaging is clinically indicated. Congestion, discharge, facial pressure, and reduced smell may continue between apparent infections.^[1][13][14]

CRS is categorized as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). This distinction matters because CRSwNP commonly has type 2, eosinophil-associated inflammation, while non-type-2 and neutrophilic patterns may be more common in CRSsNP. These patterns help specialists select testing and, in selected patients, consider biologic therapy rather than treating every flare as a new bacterial infection.^[1][14][15]

Core medical treatment includes high-volume saline irrigation and regular intranasal corticosteroids. A short oral corticosteroid course may be considered for selected acute exacerbations, especially with polyps, but its risks require individualized clinical supervision. The JAMA systematic review supports saline and topical corticosteroids as central therapies and shows why routine long-term antibiotics are not a default solution for chronic symptoms.^[1][15][17]

Several biologic medicines are FDA-approved for selected adults with CRSwNP, including dupilumab, which targets the IL-4 receptor alpha pathway, omalizumab, which targets IgE, and mepolizumab, which targets IL-5. These medicines are costly and have specific indications. The 2025 guideline advises clinicians to educate eligible patients about biologics for CRSwNP, while advising against routine biologics for CRSsNP.^[1][10][15]

Asthma, nasal polyps, and sensitivity to aspirin or other NSAIDs can occur together in aspirin-exacerbated respiratory disease, also called Samter’s triad. That phenotype, major smell loss, frequent steroid use, or recurrent symptoms after surgery deserves specialist care. Endoscopic sinus surgery may be considered for refractory disease, complications, a mucocele, fungal ball, or concern for a tumor, usually after a focused evaluation rather than by symptom duration alone.^[13][14][15]

Recurrent acute rhinosinusitis is distinct from CRS: it refers to discrete episodes with symptom-free intervals, whereas CRS leaves persistent symptoms and objective inflammation between flares. Keeping a record of episode timing, smell changes, dental symptoms, allergy seasonality, and prior treatments can make the specialist evaluation more productive.^[13][14][15]

CT imaging is not required for every stuffy nose, but it can clarify the extent and distribution of inflammation when CRS is suspected or surgery is being considered. The result must still be interpreted with symptoms and examination findings, because imaging abnormalities can occur without a bacterial flare.^{[13][14][15][27]}

Red flags: when a sinus infection is an emergency

Most sinus symptoms are not emergencies. Rarely, inflammation or infection extends beyond the sinus boundaries into the orbit, venous system, bone, or brain. The need for emergency assessment is driven by eye findings, neurologic symptoms, severe systemic illness, or rapid progression, not by ordinary congestion or colored mucus.^[18][19][32]

The classic Chandler classification describes orbital complications in five groups. Group I is preseptal or periorbital cellulitis, with eyelid inflammation but no orbital involvement. Group II is orbital cellulitis, which may cause proptosis, chemosis, and restricted eye movement. Group III is a subperiosteal abscess, Group IV is an orbital abscess, and Group V is cavernous sinus thrombosis. These distinctions require examination and often imaging, not home diagnosis.^[18][32]

Call 911 or go to the emergency department now for a bulging eye, vision change, double vision, pain with eye movement, inability to move an eye normally, new facial weakness, seizure, confusion, fainting, or severe headache with neck stiffness. Severe headache out of proportion to nasal symptoms, meningismus, altered mental status, focal weakness, or a seizure can signal intracranial extension.^[18][19][32]

Frontal sinus disease can rarely cause Pott’s puffy tumor, a frontal-bone osteomyelitis with a subperiosteal abscess that presents as tender swelling of the forehead. A person with uncontrolled diabetes, chemotherapy, transplant-related immunosuppression, or advanced HIV who develops rapid facial pain, black tissue in the nose, cranial nerve symptoms, or rapid deterioration needs urgent ENT and infectious-disease evaluation for possible invasive fungal sinusitis.^[18][19]

Children with ethmoid disease can be more vulnerable to orbital extension, and older adults with diabetes are at particular risk when fungal invasion is possible. These facts should lower the threshold for in-person evaluation when symptoms are rapidly worsening. Do not drive yourself if vision, consciousness, or neurologic function is impaired.^[18][28][32]

Rapid deterioration is particularly important because complicated sinusitis can progress over hours to days. Emergency teams may use imaging, intravenous treatment, and urgent consultation with otolaryngology, ophthalmology, neurosurgery, or infectious diseases depending on the finding. Home decongestants or a delayed outpatient appointment are not substitutes when red flags are present.^[18][19][32]

A fever by itself does not prove a complication, but fever combined with eye findings, severe unilateral swelling, a declining level of alertness, or rapidly increasing pain should be treated as a reason for immediate evaluation. Bring a medication list and describe the exact timing of the change to the emergency team.^[18][19][32]

Prevention: what actually reduces recurrence

Prevention focuses on reducing upstream inflammation and respiratory-virus exposure rather than taking antibiotics “just in case.” Hand hygiene, avoiding tobacco smoke, adequate sleep, and practical management of allergic rhinitis can reduce triggers for nasal swelling. Regular intranasal corticosteroids are helpful for many people with allergic rhinitis or chronic inflammatory disease when used as directed.^{[6][12][14][24]}

Seasonal influenza vaccination reduces the risk of influenza and its downstream respiratory complications. Pneumococcal vaccination is recommended for adults age 65 and older and for certain higher-risk adults under current U.S. vaccine guidance. These vaccines do not prevent every viral cold, but they address important respiratory pathogens for which prevention is available.^[4][6]

Humidification may improve comfort in a dry environment, but it should be paired with regular cleaning to avoid a damp, mold-prone device. Saline rinsing can be useful when symptoms or chronic inflammation are present, but routine prophylactic flushing while entirely asymptomatic has limited evidence. Dairy avoidance, garlic, and echinacea have no reliable randomized-trial support as ways to prevent ordinary recurrent sinusitis.^[12][14][17]

Prophylactic antibiotics are not a prevention strategy for uncomplicated recurrent sinus symptoms. The 2025 AAO-HNS update advises against routine antimicrobials for CRS without an acute exacerbation, and CDC stewardship principles discourage antibiotics when no bacterial indication is present. Frequent, prolonged, one-sided, dental-associated, or smell-related symptoms warrant evaluation for an underlying driver rather than repeated preventive courses.^{[1][6][10][13][31]}

For people with repeated episodes, prevention becomes more personal after the pattern is identified. Treating seasonal allergies, addressing dental disease, limiting smoke exposure, and discussing chronic symptoms with a clinician are more evidence-aligned than a standing antibiotic. This approach also avoids exposing normal bacteria to antibiotics when there is no current bacterial infection to treat.^[1][6][31]

People who use a humidifier or irrigation device should also clean it according to manufacturer instructions. Prevention measures should make the airway environment healthier, not introduce contaminated water or encourage treatment of a symptom-free nose as though it were infected.^[17][24]

Frequently Asked Questions